UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000002475
Receipt No. R000003034
Scientific Title Phase II study of combination therapy with S-1 plus cetuximab in patients with EGFR positive KRAS wild type unresectable colorectal cancer, who had previously received on irinotecan, oxaliplatin and fluoropyrimidine(KSCC0901).
Date of disclosure of the study information 2009/09/11
Last modified on 2016/09/11 16:43:08

No. Disposal Last modified on Item of update
1 Insert 2009/09/10 09:25:02
2 Update 2009/09/11 15:39:11 Public title
Public title
Acronym
Acronym
3 Update 2009/09/17 09:15:41 UMIN ID1
4 Update 2009/10/21 13:32:09 Recruitment status
5 Update 2009/11/20 14:03:33 Institutions
6 Update 2010/02/09 14:29:46 Institutions
7 Update 2010/03/30 10:23:45 Institutions
8 Update 2010/05/17 16:33:44 Institutions
9 Update 2010/05/17 17:05:19 Institutions
10 Update 2010/09/10 13:15:58 Name of person sending information
Organization
Division name
Division name
Address
Email
11 Update 2011/01/12 18:50:23 Recruitment status
12 Update 2011/09/12 14:33:48 Name of person sending information
Post marketing survey by drug manufacture etc., specified by Japanese law.
13 Update 2013/09/10 16:10:37 Email
Last name of contact person
Last name of contact person
Division name
Division name
Address
Address
Email
Name of person sending information
Name of person sending information
Organization
Organization
Division name
Division name
Address
TEL
Email
14 Update 2013/10/10 09:23:03 Last name of contact person
Last name of contact person
15 Update 2013/11/20 09:27:15 Publication of results
Results
16 Update 2014/03/10 13:38:31 Last name of contact person
Last name of contact person
17 Update 2014/03/10 13:41:25 Results
18 Update 2015/03/10 09:17:12 Key exclusion criteria
19 Update 2015/05/22 08:01:23 Email
Email
Email
20 Update 2016/09/11 16:39:09 Name of primary sponsor
Organization
21 Update 2016/09/11 16:43:08 Recruitment status
Publication of results
Results


Contact us.